Experienced in Anaphylaxis

Toshko J. Lissitchkov

BG 
Experienced in Anaphylaxis
BG 
OverviewLocationsClinical Research

Overview

Toshko Lissitchkov practices in Bulgaria. Lissitchkov is rated as an Experienced expert by MediFind in the treatment of Anaphylaxis. Their top areas of expertise are Blood Clots, Hemophilia A, Hemophilia B, and Congenital Afibrinogenemia.

Their clinical research consists of co-authoring 38 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Anaphylaxis.

Locations

Bulgaria
Other Locations
Sofia, Bulgaria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
A Prospective, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Human Plasma-derived Fibrinogen Concentrate (FIB Grifols) in Subjects With Congenital Afibrinogenaemia and Severe Hypofibrinogenemia Requiring Either On-demand Treatment for Acute Bleeding or Surgical Prophylaxis
A Prospective, Multicenter, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Human Plasma-derived Fibrinogen Concentrate (FIB Grifols) in Subjects With Congenital Afibrinogenaemia and Severe Hypofibrinogenemia Requiring Either On-demand Treatment for Acute Bleeding or Surgical Prophylaxis
Enrollment Status: Withdrawn
Publish Date: October 23, 2023
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

38 Total Publications

Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management in people with hemophilia A or B.
Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management in people with hemophilia A or B.
Journal: Blood advances
Published: June 07, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lissitchkov's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile